Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Counsyl to Present 11 Abstracts at National Society of Genetic Counselors (NSGC) Annual Education Conference

Counsyl
Posted on: 30 Sep 16

SEATTLE--(BUSINESS WIRE)--Counsyl, a DNA testing and genetic counseling service, will present significant new research findings at the National Society of Genetic Counselors (NSGC) 2016 Annual Education Conference this week at the Washington State Convention Center in Seattle, Washington.

In August 2016, Counsyl published the largest expanded carrier screening (ECS) study to date (n = 346,790) in the Journal of the American Medical Association (JAMA), which found that widespread implementation of ECS would significantly increase the detection of pregnancies affected with serious conditions across ethnicities. Data from this study, along with findings from eleven new scientific research posters and presentations, will be available at the Counsyl booth and throughout the scientific program.

Highlights from Counsyl on the NSGC scientific program include:

Thursday, September 29

Educational Breakout Session B12: Assessment of copy number variation using next generation sequencing data (Room 615-617)

Poster B-179: Clinical utility of expanded carrier screening: Reproductive behaviors of at-risk couples

Friday, September 30

Concurrent Paper Presentation Session C05: How narrow the divide: Cross lab concordance for expanded inherited cancer panel genes in ClinVar (Room 611-614)

Poster C-84: Design and enhanced validation of a 36-gene guideline-compliant inherited cancer panel

Poster C-189: Comparing the clinical yield of carrier screening: Genotyping versus exon sequencing

Counsyl is committed to sharing data with the scientific and clinical community. The company will also be exhibiting at booth #629 from Wednesday, September 28 to Friday, September 30.

The Counsyl booth will feature demos that showcase how the company’s services help to simplify billing, support genetic counselors with clear results reporting, and provide patients the best possible information and experience across Counsyl’s full-range of DNA test offerings:

Family Prep Screen: Detects couples at risk of passing inherited health conditions onto their children.

Informed Pregnancy Screen: Clarifies true risk for common aneuploidies, sex chromosome abnormalities, and microdeletions.

Inherited Cancer Screen: Identifies individuals at elevated risk for hereditary cancers.

Counsyl is proud to be a Bronze Sponsor of this year’s NSGC conference, which focuses on the latest information and educational materials for genetic counselors. Visitors to the booth may also receive a professional portrait from Counsyl’s headshot lounge.

About Counsyl

Counsyl is a DNA testing and genetic counseling service. We're committed to helping patients understand their DNA and how it can inform important health decisions. Whether it’s starting a family or evaluating risk for cancer, Counsyl's DNA tests provide patients with early awareness about genetic conditions, so they can live informed and prepare for the future. Counsyl has screened more than 600,000 patients and served more than 10,000 health care professionals.

For more information, visit www.counsyl.com.

Contacts

Counsyl
Jenna Becker
press@counsyl.com

For more information:
www.businesswire.com/news/home/20160928005415/en/Counsyl-Present-11-Abstracts-National-Society-Genetic

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 30/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.